RNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

the collaboration between BioNTech and Pfizer, including Pfizer’s investigational modified RNA (modRNA) influenza vaccine candidates, potential next-generation mRNA flu and combination vaccine ...

It all started in the lab. Two Boston University doctoral students, Joshua McGee and Jack Kirsch, were creating and testing ...

The Pfizer-BioNTech vaccine is based on novel technology to achieve this: injecting filaments of genetic instructions called 'messenger ribonucleic acid' into the body. This “messenger RNA ...

BioNTech's BNT116 is specifically engineered ... progression in the field of personalized medicine. The vaccine employs messenger RNA or mRNA technology, akin to that used in COVID-19 vaccines.

They are the husband and wife team behind one the most successful Covid vaccines ... the German company BioNTech in 2008, exploring new technology involving messenger RNA (mRNA), to treat cancer.

RNA vaccines have advantages over some other vaccine ... according to the World Health Organization. Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 ...

As your White House correspondent, I ask the tough questions and seek the answers that matter. Your support enables me to be in the room, pressing for transparency ...

This innovative project, featuring BioNTech’s BNT116 ... This cutting-edge vaccine employs messenger RNA (mRNA) technology, akin to that used in COVID-19 vaccines. However, rather than targeting ...